RADA 16-II nanofibers were employed to deliver vascular endothelial growth factor (VEGF), resulting in sustained presentation over >14 days in the myocardium and resulted in improved angiogenesis, arteriogenesis and cardiac function at 28 days post-MI in rats [74]. This evidence concerns the gene VEGFA and myocardial infarction.